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Short QT3 syndrome (SQT3S) is a cardiac disorder characterized by a high risk of mortality and associated with
mutations in Kir2.1 (KCNJ2) channels. The molecular mechanisms leading to channel dysfunction, cardiac
rhythm disturbances and neurodevelopmental disorders, potentially associated with SQT3S, remain incom-
pletely understood. Here, we report on monozygotic twins displaying a short QT interval on electrocardiogram
recordings and autism–epilepsy phenotype. Genetic screening identified a novelKCNJ2 variant in Kir2.1 that (i)
enhanced the channel’s surface expression and stability at the plasma membrane, (ii) reduced protein ubiquity-
lation and degradation, (iii) altered protein compartmentalization in lipid rafts by targeting more channels to
cholesterol-poor domains and (iv) reduced interactions with caveolin 2. Importantly, our study reveals novel
physiological mechanisms concerning wild-type Kir2.1 channel processing by the cell, such as binding to
both caveolin 1 and 2, protein degradation through the ubiquitin–proteasome pathway; in addition, it uncovers
a potential multifunctional site that controls Kir2.1 surface expression, protein half-life and partitioning to lipid
rafts. The reported mechanisms emerge as crucial also for proper astrocyte function, suggesting the need for a
neuropsychiatric evaluation in patients with SQT3S and offering new opportunities for disease management.
INTRODUCTION
Mutations in the KCNJ2 gene, encoding the inwardly rectifying
K+ channel Kir2.1, are responsible for the rare Andersen-Tawil
syndrome (OMIM170390), a condition characterizedbyperiodic
paralysis, cardiac arrhythmia and skeletal abnormalities (1).
Affected patients also display a distinct neurocognitive pheno-
type characterized by deficits in executive function and abstract
reasoning (2). The disease is linked to a loss of function ofKir2.1
channels (3). Individuals harboring mutations in KCNJ2 may
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alsopresentmooddisorders and seizures (4–6).Notably, seizure
susceptibility associated with cardiac arrhythmia have been
described in several K+ channelepsies that may increase the
risk to sudden unexpected death in affected patients (7).
SQT3s (OMIM609622) is another cardiac disorder character-
ized by QT shortening, ventricular tachyarrhythmias and atrial
fibrillation that is caused by gain-of-function mutations in
KCNJ2 (8–10).Theelectrophysiological alterations that accom-
pany SQT3S have been investigated in details demonstrating that
gain-of-function mutations in Kir2.1 caused an increase in the
amplitude of either the inward-current (such as for the D172N
variant) or outward-current (such as for the E299V and M301K
changes). To date, neither the molecular mechanisms leading to
channel dysfunction nor the potential consequence on other
organs expressing the channel, including the brain, are known.
We recently reported on two homozygous twinsmanifesting in-
tellectual disability, autism spectrumdisorder (ASD), and a history
of infantile spasms where we detected gain-of-functionmutations
inKCNJ10, encoding theKir4.1 channel (11).Thosefindingshigh-
lighted an emerging role for the inwardly rectifying K+ channels
dysfunction in autism–epilepsy associated with intellectual dis-
ability, which warranted further investigations (11,12). We herein
report on the identification of a new p.K346T mutation in KCNJ2
in cis with the previously detected p.R18Q variant in KCNJ10
(11). The pathogenic relevance of the mutation was assessed in
Xenopus laevis oocytes, HEK293 and glial-like cells. We demon-
strated that the K346T mutation causes gain of function of the
Kir2.1 channels by altering their trafficking and stabilization and
suggest that the novel KCNJ2 variant has a combined effect on
cardiac rhythm and neuropsychiatric phenotype.
RESULTS
Identification of a new KCNJ2 mutation in homozygous
twins exhibiting SQT3S and autism–epilepsy phenotype
The clinical case of the twoprobands has been reported both as SI
data and elsewhere (11). In brief, two 9-year-old identical twins
(Fig. 1A) displayed epilepsy and severe impairment of social
interaction and communication, associated with stereotypes and
repetitive behaviors, which were consistent with DSM-IV-TR
criteria for ASD. Both children showed an electrocardiogram
(ECG) with a markedly short repolarization time and conspicu-
ously narrow and peaked T waves (QTc interval, 331 ms)
(Fig. 1B). A novel heterozygous KCNJ2 variant (c.1037A.C,
p.K346T) was identified, by direct gene sequencing (Fig. 1C).
The mutation was also found in the mother but it was absent in
400 ethnically matched control chromosomes (Fig. 1A and C)
andwasnot found in largeSNPdatabases (dbSNPandeversusgs.-
washington.edu/EVS/). Multiple sequence alignment showed
that the lysine residue at position 346 (K346) is highly conserved
in several vertebrate species (Fig. 1D) and lies in the cytoplasmic
C-terminus domains of Kir2.1 channel (Fig. 1E).
Functional characterization of homo- and heteromeric
channels harboring the K346T mutation
PolyPhen-2 software analysis used to predict the impact of
the protein sequence variant p.K346T (13) suggested that
p.K346T was a highly damaging mutation with a score of
0.918 (range: 0.1 low–1 high probability of severe variant).
These findings prompted us to further investigate the pathogenic
relevance of the p.K346T mutation by two-electrode voltage-
clamp (TEVC) recording of K+ currents from X. laevis oocytes
expressing either wild-type (WT) or K346T channels (Fig. 2).
The expression of K346T channels yielded membrane currents,
recorded in high extracellular K+ concentration (90 mM KCl),
withmacroscopickinetics, inward-rectificationandpHsensitivity
(14) similar to WT (Fig. 2A and B; Supplementary Material).
However, the I–V relationships for K346T channels had larger
amplitudes than WT when equal amounts of the relevant
mRNAswere expressed (Fig. 2C). Averaged current amplitudes
linearly depended upon the amount ofmRNA injected (Fig. 2D).
Figure 1.Mutation detection by sequence analysis of the KCNJ2 coding region.
(A) Pedigree of the family harboring a novel mutations in KCNJ2. Squares are
males and circles females; solid black symbols represent propositi and slash
deceased individual. (B) ECG recording from propositi showing shortened QT
interval (heart rate, 87 bpm;QT275 ms; paper speed 25 mm/s). (C) Electropher-
ograms showing the heterozygous c.1037A.C transition (arrow-headed), pre-
dicting a novel non-synonymous p.K346T variant in propositi compared with
the sequence of a healthy individual (WT). (D) Alignments of several KCNJ2
sequences flanking the K346T substitution (K/T, arrow-headed) showing that
this residue is highly conserved in several vertebrate species. (E) Schematic re-
presentation of the membrane topology of a humanKir2.1 subunit indicating the
position of the p.K346T variant.
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To mimic the heterozygous state of the disease, WT and K346T
mRNAs were co-injected at 1:1 ratio. Also this procedure
yielded current amplitudes larger than the control (Fig. 2D).
Moreover, the evaluation of the time course of K346T channel
surface expression showed that the mutation resulted in faster
raising and slower decaying phases than the WT (Fig. 2E). To
compare these results with those obtained with the other KCNJ2
mutation associatedwithSQT3S,we expressed theKir2.1 channels
in HEK293 cells, and used a near-physiological K+ gradient. The
gain-of-function effects assessed inHEK293 cells under these con-
ditions (SupplementaryMaterial)aresimilar to theD172Nmutation
that we originally described (8), suggesting that the p.K346Tmuta-
tion results in increasedKir2.1 surface expression. However, larger
macroscopic K+ currents may result from Kir2.1 single-channel
conductance increase or channel-gating changes. To address
this issue, single-channel current recordings were performed
from X. laevis oocytes. Supplementary Material, Figure S1
shows representative recordings for WT (Supplementary Mater-
ial, Fig. S1A) and K346T (Supplementary Material, Fig. S1B)
obtained at 2100 mV in the cell-attached configuration of the
patch clamp. Event-by-event analysis revealed no significant dif-
ferences in either unitary slope conductance (WT ¼ 42.0+
1.4 pS; K346T 38.9+1.0 pS; n ¼ 6; P. 0.05) (Supplementary
Material, Fig. S1C), rectification properties or obvious changes in
gating parameters (I. Servettini, unpublished observation).
The p.K346T mutation enhances membrane expression
in astrocytoma cells
Kir2.1 channels are normally expressed in both cardiac myo-
cytes and astrocytes (15–18). Thus, to explore whether the
K346T mutation enlarges current amplitudes by increasing
surface expression of the channel in an astrocyte-like cell con-
text, we used U251MG cells stably expressing WT or K346T.
To investigate WT and mutated Kir2.1 channels intracellular
distribution in astrocytoma cells, we carried out immunofluores-
cence experiments and observed that WT channels were mostly
localized in cytoplasmic vesicles distributed in perinuclear areas
(Fig. 3A, short arrows) and, in 20–30% of the cells, also at
plasma membrane level (Fig. 3A, long arrows). The prevalent
intracellular localization of WT Kir2.1 channels in astrocytoma
cells is consistent with previous findings obtained from rodent
brain astrocytes (19). In contrast, the majority of cells (60–
80%) expressing K346T mutant showed channels abundantly
distributed along cell membranes, particularly at end-feet,
filopodia-like structures and cell–cell contacts (Fig. 3B, long
arrows), where Kir2.1 partially co-localizes with actin, and also
at intracytoplasmic vesicles (Fig. 3B).RT-PCRanalysis indicated
thatWT and K346T cells expressed comparable levels of recom-
binant genemRNAs (Fig. 3C), suggesting nodifferences in the in-
fection levels between the two cell populations. In the same
amplification conditions, no Kir2.1 mRNA could be detected in
mock-infected cells (Fig. 3C), confirming the undetectable ex-
pression of endogenousKir2.1 (18).We corroborated the immu-
nostaining differences with western blotting (WB) analysis
(Fig. 3D) that showed K346T channels more abundantly ex-
pressed thanWTproteins, particularly in themembrane-derived
protein fractions (Fig. 3D and E). Patch-clamp recordings con-
firmed these data by revealing that the resting membrane poten-
tial of cells expressing the mutant channels was on average
6 mV more negative than the WT (Fig. 3F; Supplementary
Figure 2.TheK346Tmutation increasesKir2.1 currents. Sample current families recorded fromoocytes expressingWT (A) orK346T (B)mRNA(the pulse protocol
is shown as inset). (C) I–V relationships forWT (white circles, 3 ng) and K346T (black circles, 3 ng) channels. (D) Current amplitudes recorded at2100 mV from
cells injectedwith the indicatedmRNAswhoseamounts are reported inbrackets (mean+SEM;n ¼ 120; ∗P, 0.05; ∗∗P, 0.01). (E)Current amplitudes recordedat
260 mV for WT (white circles) and K346T (black circles) channels and plotted as a function of time after mRNA injection (mean+SEM; n ¼ 6).
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Material, Fig. S2), and the current densities were larger than the
WT at both more positive and negative potentials than EK
(Fig. 3G; Supplementary Material, Fig. S2). These results
altogether indicated that the p.K346T mutation exerted gain-
of-function effects regardless of the expression system used.
The K346T mutation increases protein stability
in astrocytoma cells
The slow time course of K346T current decay over several days
after mRNA injection (see Fig. 2E), the enhancement of mem-
brane expression and current density induced by K346T in the
presence of normal mRNA expression (see above), raised the
possibility that these effects could result from increased
protein trafficking to and/or stabilization at the plasma mem-
brane. To verify this possibility, cells expressing WT and
K346T channels were treated for different periods—3, 6 and
12 h—with cycloheximide, a protein synthesis inhibitor (20).
Subsequent WB analysis revealed that degradation of WT
protein was faster than that of K346T, particularly after 12 h of
cycloheximide treatment (Fig. 4A and B), suggesting that the
p.K346T mutation results in greater protein stability.
To verify whether p.K346Tmutation influenced Kir2.1 inter-
actionswithproteinsknown tomodulate channel traffickingand/
or plasma membrane stabilization (15,21,22), we used the
His-affinity co-purification systemandWBanalysis as previous-
ly described (23,24). We tested syntrophin, a-dystrobrevin and
Rac-1, without finding significant differences in the amount of
co-purified proteins between WT and K346T expressing cells
(Supplementary Material, Fig. S3). Aquaporin-4 and connexin-
43 could not be detected among Kir2.1 interactors (M.S.
Brignone, unpublished observations). In contrast, we found the
co-presence of either Kir4.1 or Kir5.1 with Kir2.1 in the protein
eluates derived from both WT- and K346T-expressing cells,
although the mutation did not affect the possible interactions
between these subunits (Supplementary Material, Fig. S3).
K346T influences the ubiquitylation and proteasomal
degradation of Kir2.1 channels
Ubiquitin (Ub) plays an essential role in the degradationofmem-
brane proteins. Generally, the final step of the Ub-binding
cascade creates an isopeptide bond between a lysine of the
target protein and the C-terminal glycine of Ub. The in-
volvement of a lysine residue in Kir2.1 stability and its distinct
Figure 3. Characterization of astrocytoma cells expressingWT and K346T channels. Co-immunofluorescences of cells expressingWT (A) or K346T (B) channels
with anti-Kir2.1 pAb (red) and FITC-conjugated phallacidin (green) show thatWTchannels are localized in perinuclear vesicles (short arrows inA) and occasionally
at plasma membranes (long arrows in A), while mutated channels are mainly expressed at plasma membranes (long arrows in B). Scale bar: 10 mm. (C) RT-PCR
analysis of Kir2.1 mRNA inWT (1), K346T (2) channel or empty-vector expressing U251 cell lines (3). GAPDH housekeeping gene normalizes the amount of tem-
plate. (D) WB analysis of membrane (MEM) and cytosolic (CYT) proteins derived from WT or K346T Kir2.1-expressing cells after Histidine co-purification.
Molecular weight markers are on the left (kDa). (E) Densitometric analysis of protein bands from four independent experiments (mean+SEM, ∗P, 0.05).
(F) The resting membrane potential and (G) current density (at 2100 mV) were evaluated in cells expressing WT (white bars) or K346T (gray bars) channels
(data are mean+SEM; n ¼ 6; ∗P, 0.05; ∗∗P , 0.01).
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location in the cytoplasmic environment (see belowSupplemen-
tary Material, Fig. S5) let us postulate that ubiquitylation could
play a role in this process as Ub has been found to regulate
surface expression and degradation of other members of the
Kir family (25). Thus, we evaluated the background ubiquityla-
tion levels of recombinantWT and K346T proteins by perform-
ing WB analysis with anti-polyubiquitin and anti-Kir2.1
antibodies and compared with that of K346T. Equal amounts
of His-tagged WT and K346T protein eluates were resolved by
SDS–PAGE and ubiquitylation levels were evaluated by WB
(Supplementary Material, Fig. S4A). These experiments first
revealed that Kir2.1 is ubiquitylated; they also showed that the
ubiquitylation levels for K346T channels were lower than the
WT (Supplementary Material, Fig. S4A and B). We confirmed
that these data by using an in vitro ubiquitylation assay. Cells
expressing WT or K346T channels were transfected with
Ha-tagged Ub and subjected to overnight MG132 treatment to
induce inhibition of the proteosomal degradation. Kir2.1 was
immunoprecipitated in treated and control cell lysates and ubi-
quitylation rate of the WT and K346T protein was revealed by
immunoblotting (IB) versus Ub tag (Ha). Precipitation control
wasperformedby IBusinganti-Kir2.1 antibody (Supplementary
Material, Fig. S4C and D). Densitometric analysis of the result-
ingbands showeda slightly lowerubiquitylation level forK346T
comparedwithWTandproteasome inhibition byMG132didnot
produce any accumulation of K346T protein in the cell (Supple-
mentary Material, Fig. S4E and F), suggesting that the mutation
could alter targeting of the protein to the proteasomal complex
due to perturbation of physiological trafficking.
The K346T mutation affects Kir2.1 channel
compartmentalization in membrane lipid rafts
Proteins degraded by the proteasome are mainly localized in
‘lipid rafts’, specific plasma membrane compartments enriched
in cholesterol and internalized via ‘caveolae’, a subpopulation of
rafts characterized by the presence of high levels of caveolin pro-
teins forming flask-shaped membrane invaginations (26,27).
Moreover, Ub binding to protein is known for triggering
caveolin-mediated endocytosis (28). Previous studies have
shown that Kir2.1 channels have a bimodal distribution
between the raft and the non-raft membrane fractions (29,30).
Kir2.1 channels partitioned into raft domains are in a more
silent mode, whereas when they partition into non-raft
domains, they enter into a more active mode (29,30). This is
most likely caused by the different cholesterol content of each
domain. Indeed, cholesterol has been shown to reduce Kir2.1
channel functionality by inducing a prolonged closed state of
the channel (30). This notion prompted us to perform sequence
analysis of Kir2.1 which showed that K346 (red residue in:
YYKVDYSRFHKTYEV) resides in close proximity to both
a cholesterol recognition/interaction amino acid consensus
sequence (CRAC motif: V/L-X1-5-Y-X1-5-R/K—the under-
lined sequence above) and a caveolin-binding sequence
[wXXXXwXXw; w: trp (W), Phe (F) or Tyr (Y)]. Based on this
distinct body of evidence, we postulated that K346T could
affect protein-lipid interactions and in turn alter the membrane
partitioningof the channel.To test this hypothesis,weperformed
WB analysis on sucrose gradient-isolated cholesterol-rich
(triton insoluble fraction) and cholesterol-poor membrane frac-
tions (triton soluble fractions) ofWTorK346T-expressing cells.
Figure 5 shows the differential distribution of WT channels
between low- and high-density membrane fractions, whereby
they are more distributed in the triton insoluble fractions
(Fig. 5A, gray box; Fig. 5B, fractions 3–5) as previously
described (30). Conversely, the K346T mutation significantly
enhanced the amount of protein localized in cholesterol-poor
fractions (Fig. 5A, black boxes; Fig. 5C, fractions 10–12). The
higher levels of cavolin 1 (Cav-1) and flotillin-1 (Fig. 5A, D
and E) identify the caveolar lipid raft fractions enriched in chol-
esterol. These results demonstrated the presence of a larger
population of K346T channels in cholesterol-poor fractions
compared with WT and suggest that K346T-induced current
density enhancement could also bedue to reduced channel inhib-
ition occurring because of the lower levels of cholesterol in these
fractions. However, the molecular modeling and docking
Figure 4. The K346T mutation increases protein stability. (A) WB analysis of
protein extracts derived from cells expressing WT and K346T channels treated
with the protein synthesis inhibitor cycloheximide for 3, 6 and 12 h. WT
protein degradation is almost complete after 12 h treatment, while K346T
protein is still detectable at this time. Actin is used as loading control. Molecular
weightmarkers are on the left (kDa). (B) Densitometric analysis of protein bands
normalized with respect to the amount of either WT (white bar) or K346T (gray
bar) Kir2.1 protein in control conditions. Data are expressed as mean+SEM
from four independent experiments (∗∗∗P , 0.001).
Human Molecular Genetics, 2014, Vol. 23, No. 18 4879
Downloaded from https://academic.oup.com/hmg/article-abstract/23/18/4875/2900799
by UNIVERSITA DI FIRENZE DIPARTIMENTO DI PEDIATRIA user
on 28 August 2018
simulations of cholesterol revealed that K346T is located
10–14 A˚ away from theknownandnewly identified cholesterol-
binding sites (Supplementary Material, Fig. S5).
Kir2.1 interacts with Cav-1 and Cav-2 proteins
The facts that (i) theK346Tmutationalso resides in theproximity
of a putative caveolin-binding motif and (ii) caveolins influence
cell surface expression, raft compartmentalization and traffick-
ing of several type of K+ channels (31–33), prompted us to
investigate whether Kir2.1 interacts with caveolin proteins that
are expressed in cultured astrocytes (34), and the possible
effects of K346T mutation. By performing the His-affinity
co-purification assay described above, we found that Cav-1,
the main structural component of caveolar rafts, similarly inter-
actedwithWT andK346T channels (Fig. 6A andB). In contrast,
K346T mutation greatly reduced the association of Kir2.1 with
Cav-2 (Fig. 6A and B), a protein directly involved in the regula-
tion of cell signaling at raft levels (35). Cav-3, the muscle-
specific caveolin isoform, could not be detected in U251 cells
(M.S. Brignone, unpublished observation), confirming previous
findings (34). Since Cav-1 and Cav-2 can modulate channel
endocytosis leading to channel degradation or inactivation
(31–33,36) and Cav-2 can also regulate membrane protein traf-
ficking independently fromCav-1 (37), the results obtained here
suggest that the differences in the associations with Cav-2 could
influence K346T channels’ membrane compartmentalization,
stability and trafficking.
DISCUSSION
In this study, we provide new gain-of-functionmechanisms rele-
vant to understand SQT3S pathogenesis, suggest the potential
association of SQT3S with neurological disorders and uncover
a multifunctional domain in Kir2.1 that controls pivotal
properties of WT channels, such as surface expression, stability
at the plasma membrane, partitioning to lipid rafts, ubiquityla-
tion, protein degradation through proteasome and binding to
Cav-2.
The K346T mutation resulted in larger homozygous and
heterozygous K+ currents due to increased surface expression
of the channel in oocytes, HEK293 and glial-like cells. The con-
sistency of these results obtained with three very different
expression systems would exclude cell type-bound biased con-
clusions and strengthen the notion that these effects occur in
all mammalian cells that normally express this channel type
namelymyocytes, neurons and astrocytes.Notably, themutation
promotes the surface expression of the channels particularly at
end-feet, filopodia-like structures and cell–cell contacts
(Fig. 3). These structures are essential for astrocyte-mediated
K+ siphoning through Kir2.1, Kir4.1 and Kir5.1 channels, all
of which could be influenced by the K346T mutation.
It is nowwell established that the balance between trafficking
pathways to and fromcellmembrane is an important determinant
of steady-state cell surface density of membrane proteins. The
time course of Kir2.1 surface expression and degradation
suggest that the mutation hampers channel degradation and
enhances surface expression also by means of protein stabiliza-
tion at the plasma membrane. Such stability of the K346T
channel does not appears to be due to altered interactions with
syntrophin and a-dystrobrevin or Kir4.1, Kir5.1, Rac-1,
Aquaporin-4 and connexin-43. However, the direct evidence
provided here demonstrated that Kir2.1 channels are ubiquity-
lated and degraded through the Ub–proteasome pathway. The
observation that a remarkably reduced amount of K346T
protein accumulates upon proteasome inhibition with MG132,
further supports the notion that the residue K346 influences pro-
tein’s degradation/recycling. Furthermore, the fact that the
K346T mutation did not completely abolish protein’s ubiquity-
lation also suggests that other lysine residues may contribute to
this process. High-throughput screening of rodent tissues has in
Figure5.TheK346Tmutation affects the distribution ofKir2.1 channels inmembrane lipid rafts. (A)WBanalysis of cholesterol-rich (triton insoluble fractions: 3–5)
and cholesterol-poor membrane fractions (triton soluble fractions: 10–12) of WT or K346T Kir2.1-expressing cells. WT channels are mainly distributed in triton
insoluble fractions (gray box), whereas K346T is also abundantly localized in cholesterol-poor fractions (black boxes). Cav-1 and flotillin-1 identify the caveolar
raft fractions. Molecular weight markers are on the left (kDa). (B–E) Normal distributions of total protein (indicated on top) in membrane fractions isolated by
sucrose density gradient. The levels of protein in each fraction are normalized to the total protein amount recovered from all the fractions together.
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fact indicated that ubiquitylation of Kir2.1 channels occurs at
both K346 and K388 residues (38), the latter also being
exposed intracellularly (see Supplementary Material, Fig. S6).
Interestingly, ubiquitylation of Kir2.1 is tissue specific, in that
it occurs in the brain but not in the heart and skeletal muscle of
mice (38). This evidence suggests that K346T-induced deregu-
lation of Kir2.1 ubiquitylation and proteasomal degradation
may selectively alter brain, but not heart functions.
In general, membrane proteins localized in lipid rafts are
mainly internalized via caveolae and degraded by the prote-
asome, whereas membrane proteins in non-raft areas of the
membrane tend to be internalized via clathrin-coated pits and
degraded in lysosomes. The mislocalization of K346T to
non-raft areas of themembranewould thus reduce channel endo-
cytosis via caveolar pathway and degradation by proteasome
with the result of channel stabilization at plasma membrane.
The implication of trafficking/endocytosis defects is further sup-
ported by the crucial observation that K346T channels exhibit a
remarkably weaker interaction with Cav-2 compared with WT.
This decreased interaction with Cav-2 and postulated decreased
endocytic degradation or inactivation, would further account for
the enhanced stability of K346T channels andmislocalization to
non-raft regions of the plasma membrane.
Since the cholesterol content of a membrane negatively influ-
ences Kir2.1 current density due to conformational changes
leading to prolonged closed states that cannot be detected by
single-channel analysis (30,39), the demonstration that more
K346T channels are distributed in cholesterol-poor fractions,
compared with WT, can explain the larger current amplitudes
recorded from oocytes, HEK293 and glial cells, all of which
possess lipid rafts (40). Both the structural analysis of the resi-
dues known to affect the cholesterol sensitivity of several Kir
channel types and the molecular docking simulations revealed
novel-binding sites potentially involved in Kir2.1–cholesterol
interaction (Supplementary Material, Fig. S5). This analysis
also indicates that although the K346T is too far from these
binding sites, it could still affect the intrinsic cholesterol sensi-
tivity of the channels. Moreover, the location of the residue
K346 is compatiblewith the involvement of this distinct intracel-
lular domain in channel partitioning to lipid rafts, ubiquitylation,
binding to Cav-2 and trafficking. Finally, our original finding
thatCav-1 andCav-2 associatedwithKir2.1 represent an entirely
new type of protein–protein interaction thatmay have important
structural and functional implications.
Potential implications for autism–epilepsy
phenotype and SQT3 syndrome
Although it is formally possible that the KCNJ2mutation in cis
with KCNJ10 contributes separately to SQT3S or autism–
epilepsy pathogenesis, each playing a clear distinctive role,
this conclusion appears to be too simplistic. Kir2.1 channels
are highly expressed in the brain, particularly in hippocampus,
caudate, putamen, nucleus accumbens, habenula and amygdala
(41), all areas implicated in cognition, mood disorders and
ASD. As Kir2 channels, together with Kir4.1 and Kir5.1, con-
tribute to regulate neuronal excitability, cell differentiation,
synaptic plasticity and wiring, their dysfunction may impact
these crucial neurophysiological processes and result in func-
tional impairment of neural networks (further discussed in
11,12; 42–44). The clinical findings and mechanistic insights
provided here, combined with recent studies showing the pres-
ence of neuropsychiatric disorders in individuals withmutations
inKCNJ2 (2,4–6), indicate a possible role of theKir2.1 channels
in the pathogenesis of autism–epilepsy. Given that most ASD
behave as a complex multigenic disorder, Kir2.1 dysfunction
in limbic neurons and astrocytes may enhance susceptibility to
the disease when other contributing alleles (including
KCNJ10, as in our probands) are co-inherited.
In hippocampus, the amplitude of Kir2.1 currents is small in
young dentate granule neurons (DGCs) and increases 3× in
mature DGCs to optimize their excitability and, therefore,
Kir2.1 plays an important role in DGCs firing properties
during development (45). With regard to seizures, it has been
proposed that Kir2.1 upregulation in DGCs would counterbal-
ance the hyperexcitability observed in temporal lobe epilepsy
Figure6.TheK346Tmutation reducesKir2.1 channels interactionwithCav-2. (A)WBanalysis ofKir2.1 channel’s interactors afterHistidine (His) co-purificationof
astrocytoma cells expressingWT or K346T channels. Input lanes represent protein extracts before His co-purification. WT and K346T channels co-purify similarly
with Cav-1, whereas the K346T mutation reduces the association with Cav-2. One representative experiment out of three is shown. Molecular weight markers are
indicated on the left (kDa). (B) Densitometric analysis (ratio) of protein bands corresponding to Cav-1 and Cav-2 normalized respect to WT (white bars) or
K346T (gray bars) Kir2.1 protein levels. Data are expressed as mean+SEM from three independent experiments (∗∗∗P , 0.001).
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and thus function as an anti-convulsant (46). On the other hand,
upregulation ofKir2.1 channels has been observed in hippocam-
pal astrocytes following kainic acid-induced seizures (8). Thus,
whether Kir2.1 channels function as anti-convulsant or procon-
vulsant is unclear. Intriguingly, in both twins seizures had a short
course and EEGs normalized by the age of 3 years (11).
The ECG recordings and the molecular diagnosis provided
here (Fig. 1) demonstrated that bothmonozygotic twins suffered
from SQT3S, presumably resulting from larger IK1 currents.
These are thought to be predominantly carried, in the heart, by
Kir2.1 channels which contribute to fine-tune the resting mem-
brane potential and the final phase of action potential repolariza-
tion. The electrophysiological changes of IK1 properties caused
by the K346T mutation are very similar to those of the other
KCNJ2 mutation found in SQT3S (i.e. D172N; 8) and atrial
fibrillation (47), indicating that K346T likely contributes to
arrhythmia generation by affecting the excitability of myocytes.
In particular, a reciprocalmodulation ofKir2.1 andNav1.5 chan-
nels seems to be relevant to self-sustained cardiac rhythmdistur-
bances (48). Whether gain-of-function mutations in Kir2.1
enhance the availability ofNav1.5 in neurons, and if thismechan-
ismmight contribute to lowering the threshold for seizures\ASD
remains an intriguing hypothesis. Notably, the association of
cardiac arrhythmias with autism, as seen in our twins, is not en-
tirely unexpected. As a matter of fact, the phenotype of Timothy
syndrome (OMIM 601005) involves multiple organs, including
heart andbrain, and is characterized by longQTc intervals (400–
700 ms), lethal cardiac arrhythmia, seizures and ASD in over
80% of the patients (49–51). Thus, the Kir2.1 functional
defects reported here emerge as potentially crucial for astrocytes
dysfunction and suggest careful assessments for comorbid
neuropsychiatric disturbances in patients with inherited arrhyth-
mogenic diseases causedbyKir2.1 channel dysfunction.Finally,
this study also raises the question as towhether (regardless of the
distinct gain-of-function mutation causing SQT3S), hypocho-
lesterolemia would contribute to trigger SQT3 arrhythmic epi-
sodes by further increasing Kir2.1 availability, or if, vice
versa, borderline hypercholesterolemia would reduce the sever-
ity of symptoms. These assumptions, though logical in the
setting of our experimental approach, deserve further investiga-
tions in more appropriate clinical settings given their potential
impact on disease management and therapeutics.
MATERIALS AND METHODS
Genetic analyses
Total genomic DNAwas purified from peripheral blood and the
coding exons and exon–intron boundaries of KCNJ2
(NM_000891.2, NG_008798.1) were amplified by polymerase
chain reaction (PCR) using specific oligonucleotides primer
(PCR conditions upon request). The PCRproducts were bidirec-
tionally sequenced using the BigDye v3.1 chemistry (Applied
Biosystems Foster City, CA, USA). Multiple alignments with
Kir2.1 orthologs were performed using ClustalW (www.ebi.a
c.uk/clustalw/) to evaluate the degree of conservation of mis-
sense variants and Polyphen modelling analysis (http://
genetics.bwh.harvard.edu/pph/) was used to predict their effects
in silico. Healthy, ethnically matched control chromosomes
were screened by direct sequencing. Legal representatives of
patients signed informed consent prior to enrolment. The local
Institutional Review Board approved this study.
Expression of Kir2.1 channels in Xenopus oocytes
The human Kir2.1 cDNAwas introduced into in the pBF oocyte
expression vector and the K346T mutation was generated by
site-directed mutagenesis. Capped mRNAs were synthesized,
in vitro, as previously described (52–54). Xenopus laevis were
deeply anesthetized with an aerated solution containing
3-aminobenzoic acid ethyl ester methansulfonate salt (5 mM)
and sodium bicarbonate (60 mM), pH ¼ 7.3. To further reduce
their suffering, X. laevis underwent no more than two surgeries,
separated by at least 3 weeks. Stages IV–V Xenopus oocytes
were isolated, injected with 50 nl mRNAs and stored at 168C
in fresh ND96 medium containing (mM): NaCl 96, KCl 2,
MgCl2 1, CaCl2 1.8, HEPES 5, gentamicin 50 mg/ml (Sigma,
Italy). Procedures involving X. laevis and their care were in ac-
cordance with the regulations of the Italian Animal Welfare
Act and were approved by the local Authority Veterinary
Service, in agreement with the NIH Guide for the Care and
Use of Laboratory Animals. The minimal number of animals
wasused.mRNAconcentrationswerequantifiedbyelectrophor-
esis and ethidium bromide staining and by spectrophotometric
analysis. Equal amount of either WT or mutant mRNAs were
then microinjected into Xenopus oocytes according to standard
protocols.
Expression of Kir2.1 channels in HEK293 cells
The K346Tmutant was expressed in HEK293 cells by using the
same approach described previously (8). The KCNJ2 mutation
was engineered into WT cDNA cloned in pcDNA3.1 (Invitro-
gen, Life Technologies, Carlsbad, CA, USA) and confirmed by
sequence analysis. HEK 293 cells were transfected with
1.6 mg plasmid DNA of Kir2.1 WT or K346T mutant using
Effectene (Qiagen, Hilden Germany), as directed by the manu-
facturer. To mimic the heterozygous substrate, 0.8 mg of each
plasmid was transfected. In addition, 0.8 mg of GFP cDNA
was co-transfected to serve as a reporter gene.
Generation of U251 astrocytoma cell lines overexpressing
His-tagged Kir2.1 WT or carrying p.K236T mutation
and cell line treatments
AstrocytomaU251MGcell linewasobtained from theAmerican
Type Culture Collection (Rockville, MD, USA) and grown in
Dulbecco’s modified Eagle’s medium high glucose (Euroclone,
Ltd., UK) supplemented with 10% FBS (Gibco BRL, Paisley,
UK), 1% penicillin/streptomycin (Sigma Ltd, Irvine, UK) at
378C in a 5%CO2/95% air atmosphere. To generate U251 astro-
cytoma cell lines overexpressing His-tagged Kir2.1 channels,
the WT and K346T cDNAs were cloned into pcDNAV4-HIS,
aspreviously reported (24), byRT-PCRamplification (PCRcon-
ditions upon request). After sequencing analysis Kir2.1, cDNAs
were subcloned into a retroviral bicistronic vector (pQCXIN,
Takara Bio Europe Clontech, France) and transfected into a
packaging cell line (GP2, HEK293) to generate replication
incompetent retroviral particles. Viral suspensions were then
used to infect U251MG astrocytoma cell lines as described
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(55). Cells infected with virus carrying the empty vector as
control (mock-infected U251) or overexpressing recombinant
proteins (WT or K346T) were obtained by growing in G418
(Gentamicin, Euroclone) containing selective medium at a con-
centration of 600 mg/ml. For cell treatments, astrocytoma cell
lines were plated in 100-mm diameter dishes and treated for dif-
ferent time lengths (3 h, 6 h, overnight) with cycloheximide
(100 mg/ml, Sigma). After stimulation, cells were collected
and solubilized as described below. Proteins were analyzed by
SDS–PAGE and WB.
Electrophysiology
TEVC recordings were performed from oocytes at room tem-
perature (228C) and, 1–8 days after injection, by using a Gene-
Clamp 500 amplifier (Axon Instruments, Foster City, CA, USA)
interfaced to a PCcomputerwith an ITC-16 interface (Instrutech
Corporation, Longmont, CO,USA).Microelectrodeswere filled
with KCl 3 M. To avoid clamping artifacts, the current-passing
electrode was placed near the center of the cell, and low resist-
ance microelectrodes (0.1 MV) were used for the short-
duration recordings (56). Standard bath solution contained
90 mM KCl, 3 mM MgCl2, 10 mM HEPES (pH 7.4). Recordings
were filtered at 2 kHz and acquired at 5 kHzwith Pulse software
and analyzed with either PulseFit (HEKA, Germany) or IGOR
(WaveMetrics, Lake Oswego, OR, USA). Currents were
evoked by voltage commands from a holding potential of
210 mV, delivered in 210 mV increments from +50 to
2120 mV, unless otherwise stated.
Patch-clamp recordings of Xenopus oocytes were performed
at 228C using an Axopatch 200B amplifier (Axon Instruments)
as previously described (54). Oocytes were bathed in a solution
containing 120 mM KCl, 1 mM CaCl2, 11 mM EGTA, 10 mM
HEPES, 0.1 mM dithiothreitol (pH 7.2) and had resting mem-
brane potentials (Vm) of 0 mV in this ionic conditions.
Recording electrodes were pulled from borosilicate glass,
dipped in sticky wax (Kerr, Emoryville, CA, USA) prior to pol-
ishingandhad resistancesof3–8 MV. Thepipette solution, used
for single-channel recordings, contained 120 mM KCl, 10 mM
HEPES, 200 mMCaCl2 (pH 7.2). The use of high potassium con-
centrations in the pipettewas necessary to clearly resolve inward
unitary currents. Patch-clamp recordings were performed in the
cell-attached configuration by stepping to various test potentials
and assuming that the Vm of the cell was 0 mV. Junction
potentials between bath and pipette solutions were properly nul-
lified. Current traces at each holding potential were filtered at
1 kHz with a 4-pole low-pass Bessel filter and acquired at 5–
10 kHz with a Pulse+PulseFit program (HEKA Elektronik
GmbH, Germany). Channel activity was analyzed with a
TAC-TAC fit program (Bruxton Co., Seattle, WA, USA) using
the 50% threshold technique to determine the event amplitude.
Channel openingswere visually inspected before being accepted
(event-by-event mode).
Patch-clamp recordings of HEK293 or U251MG cells were
performed by using an Axopatch 700B or 200B Amplifiers
(Axon Instruments), at room temperature. The extracellular
recording solution contained (in mmol/l) NaCl 135, KCl 4.8,
CaCl2 1.8, MgCl2 1, Glucose 10 and HEPES 5; pHwas adjusted
to 7.4 with NaOH. The micropipette solution contained (in
mmol/l) KAsp 130, KCl 15, MgCl2 1, K2-ATP 2 and HEPES
5; pHwas adjusted to 7.4 with KOH. To showKir2.1 specificity,
1 mmol/l BaCl2 was added to the bath solution to block the
inward rectifying current. IK1 data were plotted as barium-
sensitive currents. Data were adjusted for the liquid junction
potential (15 mV) and presented as mean+SEM. Two-tailed
Student’s t-test was used to compare means; P , 0.05 was con-
sidered statistically significant.
Immunofluorescence and confocal microscopy analyses
Cells were grown subconfluent on polylysine-coated coverslips,
fixed for 10 min with 4% paraformaldehyde and washed with
PBS. After 1 h of incubation with blocking solution (5% BSA
in PBS), cells were incubated for 1 h at room temperature with
affinity purified anti-Kir2.1 polyclonal antibody (pAb, 1:50,
Alomone, Jerusalem, Israel) diluted in PBS, 0.025% Triton
X-100. As secondary Ab, we used TRITC-conjugated goat anti-
rabbit IgG H+L (Jackson Immunoresearch Laboratories, West
Grove, PA, USA). To stain actin filaments, an NBD phallacidin
high-affinity F-actin probe (1:30, Invitrogen, Life Technologies,
Monza, Italy) was used in combination with the primary Abs.
Coverslips were washed, sealed in Vectashield medium (Vector
Lab, Burlingame, CA, USA) and analyzed with a laser scanning
confocalmicroscope (LSM5 Pascal, Carl Zeiss, Jena, Germany).
Co-purification of histidine-tagged proteins
Lysates obtained from two 175 cm2 flasks of confluent astrocy-
toma cell lines stably overexpressing His-tagged WT and
mutated Kir2.1 and mock-infected control (U251) cells were
incubated overnight at 48C with 200 ml (50%, v/v, suspension)
ofNi-NTAAgarose (Qiagen,Hilden,Germany).After extensive
washings (10 bed volumes of 10–25–50 mM Imidazole, 0.5%
Triton X-100, 150 mM NaCl, 20 mM Tris–HCl, pH 7.4),
protein elution was carried out using 200 mM imidazole (24).
Eluted proteins were precipitated with acetone (1:4, v/v) and
analyzed by SDS–PAGE and WB.
Detergent-resistant microdomain (DMR/lipid rafts)
preparation by sucrose gradients
DRMs from cultured astrocytoma cell lines overexpressingWT
and mutated Kir2.1 were prepared as previously described (57).
Briefly, human astrocytoma cell lines were grown to confluence
in 100-mm dishes, harvested and lysed on ice with 0.75 ml of
Mes-buffered saline (25 mM MES, pH 6.5, 0.15 M NaCl) con-
taining 1% (v/v) Triton X-100 and protease inhibitors. Cell
lysate was homogenized with 10 strokes of a Dounce homogen-
izer, adjusted to40%sucrose andplaced at thebottomof anultra-
centrifuge tube. A 5–30% linear sucrose gradient was placed
above the homogenate and the mixture was centrifuged at
60 000g for 16 h at 48C in a SW61 rotor (Beckman Instruments).
Twelve 0.375-ml fractions were harvested from the top of the
gradient. The DMR fractions are visible as a light-scattering
band migrating at 20% sucrose (fractions 3, 4 and 5).
Samples were precipitated over night with acetone (1:4, v/v)
and proteins analyzed by SDS–PAGE and WB.
Protein extract preparation and WB
Astrocytoma cell lines were lysed and analyzed by WB as
previously described (24,57). For protein detection, the
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following Abs were used: anti-Kir2.1 pAb (1:250, Alomone,
Israel), anti-Kir4.1 pAb (1:400, Alomone), anti-actin mAb
(1:2000, Santa Cruz Biotecnology, Inc., Santa Cruz, CA, USA),
anti-Cav-1 pAb (1:1000, Santa Cruz Biotecnology), anti-Cav-2
pAb (1:3000, Abcam, Cambridge, UK), anti-Kir5.1 pAb (1:500,
Abcam), anti-flotillin mAb (1:1000, BD Transduction Labo-
ratories), anti-connexin-43 mAb (1:250, BD Transduction Labo-
ratories), anti-syntrophin mAb (1:200, MA-1-745, Affinity
BioReagents, CO, USA), anti-dystrobrevin mAb (1:750, BD
TransductionLaboratories), anti-RAC1mAb (1:3500,BDTrans-
duction Laboratories) and anti-Ub (P4D1) mAb (1:200, Santa
Cruz Biotecnology) in PBS+3% BSA and then incubated with
horseradish peroxidase-conjugated anti-mouse or anti-rabbit Ab
(1:10 000; Thermo Scientific, Missouri, MO, USA), for 1 h at
RT. Immunoreactive bands were visualized using an enhanced
chemiluminescence reagent (Pierce, Thermo Fisher Scientific,
Rockford, IL, USA), according to themanufacturer’s instructions
and exposed on X-ray films.
In vivo ubiquitylation assays
U251 cells were transfected with a CMVdrivenHA-Ub plasmid
(gift of Prof D. Bohmann) using Lipofectamine LTX and Plus
reagent (Life Technologies) according to the manufacturer’s
instructions. Twenty-four hours posttransfection cells treated
with 10 mMMG132 (Sigma–Aldrich) for 16 hwere trypsinized,
neutralized with complete medium and washed with PBS. For
immunoprecipitation of ubiquitinated WT and K346T mutant,
cells were lysed in protease inhibitors containing RIPA buffer.
Lysates were clarified and 1 mg of protein were precipitated
with 1:1000 mouse mAb to Xpress (Invitrogen, Life Technolo-
gies) or 1:500 Histidine tag mAb (Abcam) and 1:250 rabbit
pAb to Kir 2.1 (Alomone). Immunocomplexes recovered with
protein G-Sepharose (GE Healthcare, Milan, Italy) were
washed five times with Net Gel Buffer and boiled in 25 ml of
Laemmli buffer 2× for 5 min. Resulting immunocomplexes
were resolved on 8%–12% discontinous gradient SDS–PAGE
and transferred to nitrocellulose membrane (Bio-Rad, Milan,
Italy). Membranes were probed with mAb to HA (Cell Signal-
ing) and pAb to Kir2.1 (Alomone) and detected using
HRP-conjugated secondary antibodies (Bio-Rad) and ECL
WB reagent for chemiluminescence (Thermo Scientific).
Densitometric analyses of WB experiments were performed
using NIH ImageJ software. Ub bound was normalized to the
total immunoprecipitated Kir 2.1 amount.
STATISTICAL EVALUATION
Data are presented as means+SEM. The significance of differ-
ences between groups was investigated by ANOVA and Stu-
dent’s t-test, and the following levels of significance noted
∗P , 0.05; ∗∗P , 0.02; ∗∗∗P, 0.001.
Homology modeling and cholesterol docking
The 3D structure of Kir2.1 was built by comparative modeling
using the software Modellerw (58). The X-ray structure of the
Kir3.1-prokaryotic Kir channel chimera (PDB id.: 3JYC) was
used as a template. Sequence alignment of the target sequence
versus the template was generated using ClustalX, and further
refined using Muscle (59). The percentage of identity on the
aligned sequence was 36.7%, whereas the similarity was
66.3%; only residues 25–349 of the Kir4.1 primary structure
and residues 31–347 of the Kir5.1 sequence could be aligned
with the corresponding stretches in the X-ray template.
Twenty homology models were generated and scored against
the minimum number of constraint violations. Among them,
the five lowest energy models were selected and analyzed
using Procheck (http://www.ebi.ac.uk/thornton-srv/software/
PROCHECK/; 60). The final model was selected according to
the highest percentage of residues in the allowed region of the
Ramachandran plot (.90%). The model was then immersed
in a pre-equilibrated patch of POPC lipids bilayer and all over-
lapping lipid molecules (within 3 A˚ from any protein atoms)
were removed. Finally, the mutant protein in Kir2.1 was gener-
ated by substituting the side chain of lysine-346 with threonine
using VMD software (www.ks.uiuc.edu/Research/vmd/; 61)
and the resulting structure was further minimized to reduce
steric hindrance with neighboring atoms. Preparation of the
data, including addition of hydrogens to the ligand and the recep-
tor, determination of the rotatable bonds, partial charge distribu-
tion via the Gasteiger method (62), definition of the region of
Kir2.1 in which to execute the docking and the grid calculation
for the docking algorithms, was done with the AutoDockTools
1.5.4 program (63). The channel molecule was firstly energy
minimized using steepest descent algorithm. Docking of choles-
terol was done using the Lamarckian Genetic Algorithm proto-
col implemented in Autodock 4.2 (64). A 60 × 60 × 60 A˚3
box was built around L222 to find potential cholesterol-binding
siteswithin this box.A total of 150 runswere carriedout toobtain
50 different configurations of cholesterol bound to the Kir2.1-
binding site.Toobtain a large number of different conformations
of bound cholesterol, only runs that resulted in an RMS differ-
ence .2 A˚ were considered. During the docking procedure,
all rotatable bonds in the cholesterol molecule were allowed to
rotate. The final selected conformations of docked cholesterol
were chosen based on a cluster analysis of all the 50 conforma-
tions using a 0.5 A˚ cutoff.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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